EP 1234584 A1 20020828 - Complexes of immunoglobulins and polysaccharides for oral and transmucosal absorption
Title (en)
Complexes of immunoglobulins and polysaccharides for oral and transmucosal absorption
Title (de)
Komplexe von Immunoglobuline und Polysaccharide zur oralen oder transmukozalen Absorption
Title (fr)
Complexes d'immunoglobulines et polysaccharides absorption orale ou transmucosale
Publication
Application
Priority
IT MI20010347 A 20010221
Abstract (en)
The present invention relates to complexes consisting of immunoglobulins and polysaccharides for oral and transmucosal use. The polysaccharides comprised in the complexes according to the invention form an envelope which protects and carries immunoglobulins allowing their systemic absorption through the gastric and mucosal district. Immunoglobulins have a different specificity depending on the required therapeutic effect. They are used in passive immunoprophylaxis for the prevention or therapy of infections caused by pathogenic agents such as virus, bacteria, parasites, or they are used in the modulation of endogenous bio-chemical balances, or in the detoxification from drugs of abuse, medicines, toxins.
IPC 1-7
IPC 8 full level
A23L 1/305 (2006.01); A23L 33/00 (2016.01); A61K 39/39 (2006.01); A61K 39/395 (2006.01); A61K 39/44 (2006.01); A61K 47/36 (2006.01); A61K 47/48 (2006.01); A61P 19/10 (2006.01); A61P 31/04 (2006.01); A61P 31/12 (2006.01); A61P 33/00 (2006.01); A61P 39/02 (2006.01)
CPC (source: EP US)
A23L 33/19 (2016.07 - EP US); A61K 39/44 (2013.01 - EP US); A61K 47/6807 (2017.07 - EP US); A61P 19/10 (2017.12 - EP); A61P 31/04 (2017.12 - EP); A61P 31/12 (2017.12 - EP); A61P 33/00 (2017.12 - EP); A61P 39/02 (2017.12 - EP); A23V 2002/00 (2013.01 - EP US); A23V 2250/5434 (2013.01 - EP US); Y02A 50/30 (2017.12 - EP US)
Citation (search report)
- [X] WO 9609805 A2 19960404 - ZONAGEN INC [US]
- [Y] WO 9934831 A1 19990715 - UNIV WASHINGTON [US], et al
- [YX] WO 9730148 A1 19970821 - NOVO NORDISK AS [DK], et al
- [X] WO 9837200 A2 19980827 - GENENTECH INC [US], et al
- [X] US 5747475 A 19980505 - NORDQUIST ROBERT E [US], et al
- [X] EP 0315456 A2 19890510 - HYBRITECH INC [US]
- [X] US 5380513 A 19950110 - GRAY MARY A [US], et al
- [X] US 5530102 A 19960625 - GRISTINA ANTHONY G [US], et al
- [A] JOHANSEN, HELLE KROGH ET AL: "Immunization with Pseudomonas aeruginosa vaccines and adjuvant can modulate the type of inflammatory response subsequent to infection", INFECT. IMMUN. (1994), 62(8), 3146-55, XP001010133
Citation (examination)
- WO 9600081 A1 19960104 - IMMUNEX CORP [US]
- EP 0635261 A1 19950125 - LIPOTEC SA [ES]
- WO 9830207 A1 19980716 - DANBIOSYST UK [GB], et al
- WO 0238123 A1 20020516 - WADLUND AS [NO], et al
- AKIRA MOCHIZUKI ET AL: "PERVAPORATION SEPARATION OF WATER/ETHANOL MIXTURES THROUGH POLYSACCHARIDE MEMBRANES. V. THE RELATIONSHIPS BETWEEN THE PERMSELECTIVITY OF CHITOSAN SALT MEMBRANE AND ITS SOLID STATE STRUCTURE", JOURNAL OF APPLIED POLYMER SCIENCE, vol. 40, 1990, pages 633 - 643, XP000168967, ISSN: 0021-8995
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
EP 1234584 A1 20020828; IT MI20010347 A1 20020821; JP 2002332243 A 20021122; US 2003068315 A1 20030410; US 2005191289 A1 20050901; US 6913746 B2 20050705; US 7189395 B2 20070313
DOCDB simple family (application)
EP 02003798 A 20020220; IT MI20010347 A 20010221; JP 2002045088 A 20020221; US 10253705 A 20050407; US 8108102 A 20020220